RedChip Companies will air interviews with Connect Biopharma Holdings Limited (Nasdaq:CNTB) and Bimergen Energy Corp.
Pollution-related illnesses surge, with treatment costs rising 11%, particularly affecting children, warns a Policybazaar report.
Wakefield Express on MSN
COPD clinical trial: Mid Yorkshire Teaching NHS Trust recruits first patient to new COPD clinical trial
Mid Yorkshire Teaching NHS Trust has become the first site in Europe to recruit a patient to a major international clinical ...
Use of a COPD care pathway heightened the odds for a pulmonary rehabilitation referral and home discharge in hospitalized ...
Anyone who breathes can develop COPD. The world is at risk, and chronic respiratory diseases must be treated as both a global ...
Adequate management of COPD is important because hospitalisation for an acute exacerbation of COPD (AECOPD) is associated ...
Patients in the UK will be able to access cutting-edge testing for Chronic Obstructive Pulmonary Disease (COPD) - the UK’s sixth biggest killer - as the NHS rolls out faster, more accessible ...
ORLANDO, FL / ACCESS Newswire / November 14, 2025 / RedChip Companies will air interviews with Connect Biopharma Holdings Limited (Nasdaq:CNTB) and Bimergen Energy Corp. (OCTQB:BESS) on the RedChip Sm ...
Adults hospitalized for acute COPD exacerbation faced elevated odds for all-cause mortality and ICU admission if they had end-stage renal disease and were on dialysis, according to data presented at ...
Melbourne-based RAGE Biotech has raised $29 million in Series A to take its treatment for chronic lung disease into ...
The findings are stark: seven in ten residents say they have “no or very low confidence” in the ability of government ...
The CT-based whole-lung radiomic nomogram accurately identifies AECOPD and offers a robust tool for clinical diagnosis and treatment planning.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback